SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- Complex day on Twitter: Elon Musk announces massive layoffs of workers on the social network Nov 6, 2022
- The Giro d’Italia arrives in Slovenia: this is how the mid-mountain stage 19 will be run on May 27 May 27, 2022
- Salobreña Sea Stain Reappears | Costa Tropical Gazette News Jul 27, 2021
- Fleury resumes main customer services after hacker attack – ISTOÉ MONEY Jun 30, 2021
- Kai Pflaume posts this photo – TV colleague makes a direct request Apr 19, 2021
- Sainz and Ferrari 2022: “I’ve been trying it since January” | FormulaPassion.it Jul 4, 2021
- Lawyers for Bill Cosby cry as sexual assault civil trial approaches May 21, 2022